LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

Search

Merit Medical Systems Inc

Deschisă

SectorSănătate

80 0.55

Rezumat

Modificarea prețului

24h

Curent

Minim

79.48

Maxim

81.53

Indicatori cheie

By Trading Economics

Venit

-4.8M

28M

Vânzări

1.7M

384M

P/E

Medie Sector

41.451

121.746

Marjă de profit

7.225

Angajați

7,400

EBITDA

-4.4M

80M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+30.31% upside

Dividende

By Dow Jones

Următoarele câștiguri

24 feb. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-108M

4.8B

Deschiderea anterioară

79.45

Închiderea anterioară

80

Sentimentul știrilor

By Acuity

50%

50%

149 / 352 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

Merit Medical Systems Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

11 feb. 2026, 23:47 UTC

Acțiuni populare

Stocks to Watch: AppLovin, Cisco, Cognex, Pilgrim's Pride

11 feb. 2026, 22:59 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Grab Holdings to Buy U.S.-Based Stash Financial

11 feb. 2026, 23:54 UTC

Câștiguri

McDonald's Says Its Value Campaign Is Paying Off -- 2nd Update

11 feb. 2026, 23:50 UTC

Market Talk

Global Equities Roundup: Market Talk

11 feb. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Takaichi's Economic Steps -- Market Talk

11 feb. 2026, 23:49 UTC

Câștiguri

Singtel: Key Focus Areas Are Strengthening Core Businesses, Scaling Growth Engines, Building Momentum Across Regional Associates >Z74.SG

11 feb. 2026, 23:45 UTC

Câștiguri

Singtel: Net Exceptional Gain of S$1.15B in 3Q Primarily From Sale of Partial Stake in Bharti Airtel>Z74.SG

11 feb. 2026, 23:42 UTC

Câștiguri

Singtel 3Q Underlying Net Profit S$744M Vs. S$680M >Z74.SG

11 feb. 2026, 23:41 UTC

Câștiguri

Singtel 3Q Net S$1.89B Vs. Net S$1.32B >Z74.SG

11 feb. 2026, 23:40 UTC

Câștiguri

Singtel 3Q Operating Revenue S$3.66B Vs. S$3.63B >Z74.SG

11 feb. 2026, 23:35 UTC

Market Talk

Gold Falls on Prospects of Long Fed Pause -- Market Talk

11 feb. 2026, 23:18 UTC

Market Talk

AppLovin CEO Looks to Soothe Concerns Over AI, Competition -- Market Talk

11 feb. 2026, 23:14 UTC

Market Talk

RBA Governor Faces Barrage of Questions About Govt Spending -- Market Talk

11 feb. 2026, 22:59 UTC

Câștiguri

Kakao 2025 Net KRW525.72B Vs. Loss KRW161.87B >035720.SE

11 feb. 2026, 22:59 UTC

Câștiguri

Kakao 2025 Oper Pft KRW732.04B Vs. Pft KRW460.21B >035720.SE

11 feb. 2026, 22:59 UTC

Câștiguri

Kakao 2025 Rev KRW8.099T Vs. KRW7.872T >035720.SE

11 feb. 2026, 22:58 UTC

Câștiguri

Kakao 4Q Net Loss Missed FactSet-Compiled Consensus

11 feb. 2026, 22:57 UTC

Câștiguri

Kakao 4Q Loss KRW39.30B Vs. Loss KRW395.21B >035720.SE

11 feb. 2026, 22:54 UTC

Câștiguri

Kakao 4Q Oper Pft KRW203.45B Vs. Pft KRW75.43B >035720.SE

11 feb. 2026, 22:53 UTC

Câștiguri

Kakao 4Q Rev KRW2.133T Vs. KRW1.957T >035720.SE

11 feb. 2026, 22:47 UTC

Câștiguri

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11 feb. 2026, 22:47 UTC

Câștiguri

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11 feb. 2026, 22:23 UTC

Câștiguri

Grab Holdings Expects to Close Stash Acquisition in 3Q of 2026 >GRAB

11 feb. 2026, 22:22 UTC

Câștiguri

Grab Holdings to Acquire U.S. Digital Financial Services Company Stash Financial >GRAB

11 feb. 2026, 22:22 UTC

Câștiguri

Grab Holdings Sees FY26 Adj Ebitda $700M to $720M >GRAB

11 feb. 2026, 22:19 UTC

Câștiguri

Grab Holdings Sees FY26 Rev $4.04B to $4.10B >GRAB

11 feb. 2026, 22:18 UTC

Câștiguri

Grab Holdings 4Q Adj Ebitda $148.0M Vs. $97.0M >GRAB

11 feb. 2026, 22:18 UTC

Câștiguri

Grab Holdings 4Q Net $153.0M Vs. Net $11.0M >GRAB

11 feb. 2026, 22:18 UTC

Câștiguri

Grab Holdings 4Q Oper Pft $52.0M Vs. $2.0M >GRAB

11 feb. 2026, 22:16 UTC

Câștiguri

Grab Holdings 4Q Rev $906.0M Vs. $764.0M >GRAB

Comparație

Modificare preț

Merit Medical Systems Inc Așteptări

Obiectiv de preț

By TipRanks

30.31% sus

Prognoză pe 12 luni

Medie 105.33 USD  30.31%

Maxim 122 USD

Minim 90 USD

În baza a 9 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruMerit Medical Systems Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

9 ratings

8

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

95.585 / 96.35Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

149 / 352 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Merit Medical Systems Inc

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
help-icon Live chat